Hepatitis B virus
Intrahepatic and peripheral blood virus-specific cytotoxic T lymphocyte activity is associated with a response to combination IFN-α and ribavirin treatment among patients with chronic hepatitis C virus infection*
Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C
Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection
Hot-spot mutations in hepatitis B virus core gene
Long-term follow-up of chronic hepatitis B after the emergence of mutations in the hepatitis B virus polymerase region
Low frequency of mutations in the X gene, core promoter and precore region of hepatitis B virus infected Vietnamese
Quantification of the relative levels of wild-type and lamivudine-resistant mutant virus in serum of HBV-infected patients using microarray
Factors associated with the initiation of alpha-interferon treatment in Medicaid patients diagnosed with hepatitis C
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B
Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States
Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B
Treatment of acute hepatitis C infection in HIV-infected patients
HBV vaccination in liver transplant recipients
Monitoring of HBeAg levels may help to predict the outcomes of lamivudine therapy for HBeAg positive chronic hepatitis B